Arcus Biosciences Inc (RCUS)

Current ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Total current assets	US$ in thousands	831,000	882,000	986,000	1,015,000	1,067,000	1,101,120	1,227,480	1,264,230	1,262,000	545,288	745,954	841,870	735,815	797,199	471,599	166,217	192,705	200,488	227,733	245,015
Total current liabilities	US$ in thousands	184,000	200,000	180,000	179,000	193,000	177,176	164,024	161,254	166,000	142,866	130,370	132,055	121,669	162,871	40,025	21,004	22,706	21,057	26,513	19,003
Current ratio		4.52	4.41	5.48	5.67	5.53	6.21	7.48	7.84	7.60	3.82	5.72	6.38	6.05	4.89	11.78	7.91	8.49	9.52	8.59	12.89

December 31, 2023 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $831,000K ÷ $184,000K
= 4.52

The current ratio of Arcus Biosciences Inc has shown a declining trend over the past few quarters, indicating a potential decrease in its short-term liquidity and ability to cover its current liabilities with its current assets. Despite this, the current ratio remains relatively high, ranging from 4.41 to 7.84, which suggests that the company still has a strong ability to meet its short-term financial obligations. However, the decreasing trend may warrant further investigation into the company's management of current assets and liabilities to ensure sustainable liquidity levels in the future.